Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Evangelos Stelios Gragoudas, M.D.

TitleCharles Edward Whitten Professor of Ophthalmology
InstitutionMassachusetts Eye and Ear Infirmary
DepartmentOphthalmology
AddressMassachusetts Eye & Ear Infrm
Ophthalmology
243 Charles St
Boston MA 02114
Phone617/573-3515
Fax617/573-3698

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Jakobiec FA, Gragoudas ES, Colby KA. Biopsy of an anterior episcleral nodule as an aid in managing a ciliary body melanocytic tumor. Cornea. 2013 Aug; 32(8):1174-7.
    View in: PubMed
  2. Theodoropoulou S, Brodowska K, Kayama M, Morizane Y, Miller JW, Gragoudas ES, Vavvas DG. Aminoimidazole Carboxamide Ribonucleotide (AICAR) Inhibits the Growth of Retinoblastoma In Vivo by Decreasing Angiogenesis and Inducing Apoptosis. PLoS One. 2013; 8(1):e52852.
    View in: PubMed
  3. Daniels AB, Lee JE, Macconaill LE, Palescandolo E, Van Hummelen P, Adams SM, Deangelis MM, Hahn WC, Gragoudas ES, Harbour JW, Garraway LA, Kim IK. High throughput mass spectrometry-based mutation profiling of primary uveal melanoma. Invest Ophthalmol Vis Sci. 2012 Oct; 53(11):6991-6.
    View in: PubMed
  4. Rao RC, Choudhry N, Gragoudas ES. Enhanced depth imaging spectral-domain optical coherence tomography findings in sclerochoroidal calcification. Retina. 2012 Jun; 32(6):1226-7.
    View in: PubMed
  5. Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, DeAngelis MM, Gragoudas E, Duncan LM, Tsao H. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One. 2012; 7(4):e35295.
    View in: PubMed
  6. Cohen SJ, Chan RV, Keegan M, Andreoli CM, Borenstein JT, Miller JW, Gragoudas ES. Evaluation of tissue interactions with mechanical elements of a transscleral drug delivery device. Pharmaceutics. 2012; 4(1):212-29.
    View in: PubMed
  7. Lane AM, Kim IK, Gragoudas ES. Proton irradiation for peripapillary and parapapillary melanomas. Arch Ophthalmol. 2011 Sep; 129(9):1127-30.
    View in: PubMed
  8. Shildkrot Y, Sobrin L, Gragoudas ES. Cancer-associated retinopathy: update on pathogenesis and therapy. Semin Ophthalmol. 2011 Jul-Sep; 26(4-5):321-8.
    View in: PubMed
  9. Giani A, Thanos A, Roh MI, Connolly E, Trichonas G, Kim I, Gragoudas E, Vavvas D, Miller JW. In vivo evaluation of laser-induced choroidal neovascularization using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2011 May; 52(6):3880-7.
    View in: PubMed
  10. Salehi-Had H, Roh MI, Giani A, Hisatomi T, Nakao S, Kim IK, Gragoudas ES, Vavvas D, Guccione S, Miller JW. Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularization. PLoS One. 2011; 6(4):e18864.
    View in: PubMed
  11. Vavvas D, Kim I, Lane AM, Chaglassian A, Mukai S, Gragoudas E. Posterior uveal melanoma in young patients treated with proton beam therapy. Retina. 2010 Sep; 30(8):1267-71.
    View in: PubMed
  12. Lane AM, Egan KM, Kim IK, Gragoudas ES. Mortality after diagnosis of small melanocytic lesions of the choroid. Arch Ophthalmol. 2010 Aug; 128(8):996-1000.
    View in: PubMed
  13. Kim IK, Lane AM, Gragoudas ES. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma. Arch Ophthalmol. 2010 Jul; 128(7):871-5.
    View in: PubMed
  14. Marucci L, Ancukiewicz M, Lane AM, Collier JM, Gragoudas ES, Munzenrider JE. Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation. Int J Radiat Oncol Biol Phys. 2011 Mar 1; 79(3):842-6.
    View in: PubMed
  15. Theodoropoulou S, Kolovou PE, Morizane Y, Kayama M, Nicolaou F, Miller JW, Gragoudas E, Ksander BR, Vavvas DG. Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase. FASEB J. 2010 Aug; 24(8):2620-30.
    View in: PubMed
  16. Kim IK, Lane AM, Egan KM, Munzenrider J, Gragoudas ES. Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma. Ophthalmology. 2010 Aug; 117(8):1617-22.
    View in: PubMed
  17. Chan RV, Yonekawa Y, Lane AM, Skondra D, Munzenrider JE, Collier JM, Gragoudas ES, Kim IK. Proton beam irradiation using a light-field technique for the treatment of choroidal hemangiomas. Ophthalmologica. 2010; 224(4):209-16.
    View in: PubMed
  18. Trichonas G, Manola A, Morizane Y, Thanos A, Koufomichali X, Papakostas TD, Montezuma S, Young L, Miller JW, Gragoudas E, Vavvas D. A novel nonradioactive method to evaluate vascular barrier breakdown and leakage. Invest Ophthalmol Vis Sci. 2010 Mar; 51(3):1677-82.
    View in: PubMed
  19. Lane AM, Egan KM, Harmon D, Holbrook A, Munzenrider JE, Gragoudas ES. Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis. Ophthalmology. 2009 Nov; 116(11):2206-12.
    View in: PubMed
  20. Iliaki E, Poulaki V, Mitsiades N, Mitsiades CS, Miller JW, Gragoudas ES. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009 Oct; 50(10):4898-904.
    View in: PubMed
  21. Kim IK, Gragoudas ES. Radiation therapy for neovascular age-related macular degeneration revisited. Br J Ophthalmol. 2009 Mar; 93(3):279-80.
    View in: PubMed
  22. Esmaili DD, Mukai S, Jakobiec FA, Kim IK, Gragoudas ES. Ocular melanocytoma. Int Ophthalmol Clin. 2009; 49(1):165-75.
    View in: PubMed
  23. Noda K, She H, Nakazawa T, Hisatomi T, Nakao S, Almulki L, Zandi S, Miyahara S, Ito Y, Thomas KL, Garland RC, Miller JW, Gragoudas ES, Mashima Y, Hafezi-Moghadam A. Vascular adhesion protein-1 blockade suppresses choroidal neovascularization. FASEB J. 2008 Aug; 22(8):2928-35.
    View in: PubMed
  24. She H, Nakazawa T, Matsubara A, Connolly E, Hisatomi T, Noda K, Kim I, Gragoudas ES, Miller JW. Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2008 Nov; 49(11):5008-14.
    View in: PubMed
  25. Yu HG, Liu X, Kiss S, Connolly E, Gragoudas ES, Michaud NA, Bulgakov OV, Adamian M, DeAngelis MM, Miller JW, Li T, Kim IK. Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1. Invest Ophthalmol Vis Sci. 2008 Jun; 49(6):2599-605.
    View in: PubMed
  26. Skondra D, Noda K, Almulki L, Tayyari F, Frimmel S, Nakazawa T, Kim IK, Zandi S, Thomas KL, Miller JW, Gragoudas ES, Hafezi-Moghadam A. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown. Invest Ophthalmol Vis Sci. 2008 Feb; 49(2):726-31.
    View in: PubMed
  27. Miyahara S, Almulki L, Noda K, Nakazawa T, Hisatomi T, Nakao S, Thomas KL, Schering A, Zandi S, Frimmel S, Tayyari F, Garland RC, Miller JW, Gragoudas ES, Masli S, Hafezi-Moghadam A. In vivo imaging of endothelial injury in choriocapillaris during endotoxin-induced uveitis. FASEB J. 2008 Jun; 22(6):1973-80.
    View in: PubMed
  28. Noda K, Miyahara S, Nakazawa T, Almulki L, Nakao S, Hisatomi T, She H, Thomas KL, Garland RC, Miller JW, Gragoudas ES, Kawai Y, Mashima Y, Hafezi-Moghadam A. Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis. FASEB J. 2008 Apr; 22(4):1094-103.
    View in: PubMed
  29. Matsubara A, Nakazawa T, Noda K, She H, Connolly E, Young TA, Ogura Y, Gragoudas ES, Miller JW. Photodynamic therapy induces caspase-dependent apoptosis in rat CNV model. Invest Ophthalmol Vis Sci. 2007 Oct; 48(10):4741-7.
    View in: PubMed
  30. Marneros AG, She H, Zambarakji H, Hashizume H, Connolly EJ, Kim I, Gragoudas ES, Miller JW, Olsen BR. Endogenous endostatin inhibits choroidal neovascularization. FASEB J. 2007 Dec; 21(14):3809-18.
    View in: PubMed
  31. She H, Nakazawa T, Matsubara A, Hisatomi T, Young TA, Michaud N, Connolly E, Hafezi-Moghadam A, Gragoudas ES, Miller JW. Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2007 May; 48(5):2268-77.
    View in: PubMed
  32. Poulaki V, Iliaki E, Mitsiades N, Mitsiades CS, Paulus YN, Bula DV, Gragoudas ES, Miller JW. Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis. FASEB J. 2007 Jul; 21(9):2113-23.
    View in: PubMed
  33. Hafezi-Moghadam A, Noda K, Almulki L, Iliaki EF, Poulaki V, Thomas KL, Nakazawa T, Hisatomi T, Miller JW, Gragoudas ES. VLA-4 blockade suppresses endotoxin-induced uveitis: in vivo evidence for functional integrin up-regulation. FASEB J. 2007 Feb; 21(2):464-74.
    View in: PubMed
  34. Gragoudas ES. Proton beam irradiation of uveal melanomas: the first 30 years. The Weisenfeld Lecture. Invest Ophthalmol Vis Sci. 2006 Nov; 47(11):4666-73.
    View in: PubMed
  35. Zambarakji HJ, Lane AM, Ezra E, Gauthier D, Goitein M, Adams JA, Munzenrider JE, Miller JW, Gragoudas ES. Proton beam irradiation for neovascular age-related macular degeneration. Ophthalmology. 2006 Nov; 113(11):2012-9.
    View in: PubMed
  36. Chen TC, Cense B, Miller JW, Rubin PA, Deschler DG, Gragoudas ES, de Boer JF. Histologic correlation of in vivo optical coherence tomography images of the human retina. Am J Ophthalmol. 2006 Jun; 141(6):1165-8.
    View in: PubMed
  37. Matsubara A, Nakazawa T, Husain D, Iliaki E, Connolly E, Michaud NA, Gragoudas ES, Miller JW. Investigating the effect of ciliary body photodynamic therapy in a glaucoma mouse model. Invest Ophthalmol Vis Sci. 2006 Jun; 47(6):2498-507.
    View in: PubMed
  38. Zambarakji HJ, Nakazawa T, Connolly E, Lane AM, Mallemadugula S, Kaplan M, Michaud N, Hafezi-Moghadam A, Gragoudas ES, Miller JW. Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2006 Jun; 47(6):2623-31.
    View in: PubMed
  39. Kim IK, Dryja TP, Lessell S, Gragoudas ES. Melanocytoma of the optic nerve associated with sound-induced phosphenes. Arch Ophthalmol. 2006 Feb; 124(2):273-7.
    View in: PubMed
  40. Marucci L, Lane AM, Li W, Egan KM, Gragoudas ES, Adams JA, Collier JM, Munzenrider JE. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma. Int J Radiat Oncol Biol Phys. 2006 Mar 15; 64(4):1018-22.
    View in: PubMed
  41. Kim IK, Husain D, Michaud N, Connolly E, Lane AM, Durrani K, Hafezi-Moghadam A, Gragoudas ES, O'Neill CA, Beyer JC, Miller JW. Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid. Invest Ophthalmol Vis Sci. 2006 Jan; 47(1):357-63.
    View in: PubMed
  42. Kalayoglu MV, Bula D, Arroyo J, Gragoudas ES, D'Amico D, Miller JW. Identification of Chlamydia pneumoniae within human choroidal neovascular membranes secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2005 Nov; 243(11):1080-90.
    View in: PubMed
  43. Husain D, Kim I, Gauthier D, Lane AM, Tsilimbaris MK, Ezra E, Connolly EJ, Michaud N, Gragoudas ES, O'Neill CA, Beyer JC, Miller JW. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey. Arch Ophthalmol. 2005 Apr; 123(4):509-16.
    View in: PubMed
  44. Gragoudas ES, Marie Lane A. Uveal melanoma: proton beam irradiation. Ophthalmol Clin North Am. 2005 Mar; 18(1):111-8, ix.
    View in: PubMed
  45. Tsina EK, Lane AM, Zacks DN, Munzenrider JE, Collier JM, Gragoudas ES. Treatment of metastatic tumors of the choroid with proton beam irradiation. Ophthalmology. 2005 Feb; 112(2):337-43.
    View in: PubMed
  46. Bhisitkul RB, Robinson GS, Moulton RS, Claffey KP, Gragoudas ES, Miller JW. An antisense oligodeoxynucleotide against vascular endothelial growth factor in a nonhuman primate model of iris neovascularization. Arch Ophthalmol. 2005 Feb; 123(2):214-9.
    View in: PubMed
  47. Gragoudas ES, Adamis AP, Cunningham ET, Feinsod M, Guyer DR. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004 Dec 30; 351(27):2805-16.
    View in: PubMed
  48. Renno RZ, Terada Y, Haddadin MJ, Michaud NA, Gragoudas ES, Miller JW. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2. Arch Ophthalmol. 2004 Jul; 122(7):1002-11.
    View in: PubMed
  49. Krause MH, Kwong KK, Gragoudas ES, Young LH. MRI of blood volume with superparamagnetic iron in choroidal melanoma treated with thermotherapy. Magn Reson Imaging. 2004 Jul; 22(6):779-87.
    View in: PubMed
  50. Yeh DC, Bula DV, Miller JW, Gragoudas ES, Arroyo JG. Expression of leukocyte adhesion molecules in human subfoveal choroidal neovascular membranes treated with and without photodynamic therapy. Invest Ophthalmol Vis Sci. 2004 Jul; 45(7):2368-73.
    View in: PubMed
  51. Zhao JC, Zacks DN, Gragoudas ES, Pasquale LR. Pupil sparing excision of an atypical iris melanocytoma induces remission of secondary glaucoma. Br J Ophthalmol. 2004 Jun; 88(6):842-3.
    View in: PubMed
  52. Azab M, Benchaboune M, Blinder KJ, Bressler NM, Bressler SB, Gragoudas ES, Fish GE, Hao Y, Haynes L, Lim JI, Menchini U, Miller JW, Mones J, Potter MJ, Reaves A, Rosenfeld PJ, Strong A, Su XY, Slakter JS, Schmidt-Erfurth U, Sorenson JA. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4. Retina. 2004 Feb; 24(1):1-12.
    View in: PubMed
  53. Ufret-Vincenty RL, Miller JW, Gragoudas ES. Photosensitizers in photodynamic therapy of choroidal neovascularization. Int Ophthalmol Clin. 2004; 44(3):63-80.
    View in: PubMed
  54. Vavvas D, Gragoudas ES, Hatton MP. Preface. Int Ophthalmol Clin. 2004; 44(3):xiii.
    View in: PubMed
  55. Krause MH, Kwong KK, Xiong J, Gragoudas ES, Young LH. MRI of blood volume with MS 325 in experimental choroidal melanoma. Magn Reson Imaging. 2003 Sep; 21(7):725-32.
    View in: PubMed
  56. Ishida S, Usui T, Yamashiro K, Kaji Y, Amano S, Ogura Y, Hida T, Oguchi Y, Ambati J, Miller JW, Gragoudas ES, Ng YS, D'Amore PA, Shima DT, Adamis AP. VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J Exp Med. 2003 Aug 4; 198(3):483-9.
    View in: PubMed
  57. Sakurai E, Taguchi H, Anand A, Ambati BK, Gragoudas ES, Miller JW, Adamis AP, Ambati J. Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003 Jun; 44(6):2743-9.
    View in: PubMed
  58. Krause MH, Xiong J, Gragoudas ES, Young LH. Treatment of experimental choroidal melanoma with an Nd:yttrium-lanthanum-fluoride laser at 1047 nm. Arch Ophthalmol. 2003 Mar; 121(3):357-63.
    View in: PubMed
  59. Li W, Gragoudas ES, Egan KM. Tumor basal area and metastatic death after proton beam irradiation for choroidal melanoma. Arch Ophthalmol. 2003 Jan; 121(1):68-72.
    View in: PubMed
  60. Carrasquillo KG, Ricker JA, Rigas IK, Miller JW, Gragoudas ES, Adamis AP. Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres. Invest Ophthalmol Vis Sci. 2003 Jan; 44(1):290-9.
    View in: PubMed
  61. Gragoudas E, Li W, Goitein M, Lane AM, Munzenrider JE, Egan KM. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol. 2002 Dec; 120(12):1665-71.
    View in: PubMed
  62. Bressler NM, Arnold J, Benchaboune M, Blumenkranz MS, Fish GE, Gragoudas ES, Lewis H, Schmidt-Erfurth U, Slakter JS, Bressler SB, Manos K, Hao Y, Hayes L, Koester J, Reaves A, Strong HA. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. Arch Ophthalmol. 2002 Nov; 120(11):1443-54.
    View in: PubMed
  63. Fernandez-Suntay JP, Gragoudas ES, Ferry JA, Anderson ME, Dacey MP, Dryja TP. High-grade uveal B-cell lymphoma as the initial feature in Richter syndrome. Arch Ophthalmol. 2002 Oct; 120(10):1383-5.
    View in: PubMed
  64. Chen S, Gragoudas E. Complications of cataract extraction. Semin Ophthalmol. 2002 Sep-Dec; 17(3-4):101.
    View in: PubMed
  65. Hu L, Wu X, Song Y, Young LH, Gragoudas ES. [Photodynamic therapy of pigmented choroidal melanomas in rabbits]. Zhonghua Yan Ke Za Zhi. 2002 Aug; 38(8):491-4.
    View in: PubMed
  66. Zacks DN, Ezra E, Terada Y, Michaud N, Connolly E, Gragoudas ES, Miller JW. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization. Invest Ophthalmol Vis Sci. 2002 Jul; 43(7):2384-91.
    View in: PubMed
  67. Krause M, Kwong KK, Xiong J, Gragoudas ES, Young LH. MRI of blood volume and cellular uptake of superparamagnetic iron in an animal model of choroidal melanoma. Ophthalmic Res. 2002 Jul-Aug; 34(4):241-50.
    View in: PubMed
  68. Renno RZ, Youssri AI, Michaud N, Gragoudas ES, Miller JW. Expression of pigment epithelium-derived factor in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2002 May; 43(5):1574-80.
    View in: PubMed
  69. Krzystolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, Michaud NA, Li W, Connolly E, O'Neill CA, Miller JW. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol. 2002 Mar; 120(3):338-46.
    View in: PubMed
  70. Haimovici R, Ciulla TA, Miller JW, Hasan T, Flotte TJ, Kenney AG, Schomacker KT, Gragoudas ES. Localization of rose bengal, aluminum phthalocyanine tetrasulfonate, and chlorin e6 in the rabbit eye. Retina. 2002 Feb; 22(1):65-74.
    View in: PubMed
  71. Haimovici R, D'Amico DJ, Gragoudas ES, Sokol S. The expanded clinical spectrum of deferoxamine retinopathy. Ophthalmology. 2002 Jan; 109(1):164-71.
    View in: PubMed
  72. Gragoudas ES, Lane AM, Munzenrider J, Egan KM, Li W. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc. 2002; 100:43-8; discussion 48-9.
    View in: PubMed
  73. Zacks DN, Pinnolis MK, Berson EL, Gragoudas ES. Melanoma-associated retinopathy and recurrent exudative retinal detachments in a patient with choroidal melanoma. Am J Ophthalmol. 2001 Oct; 132(4):578-81.
    View in: PubMed
  74. Regan S, Egan KM, Hart L, Gragoudas ES. Color Doppler imaging of untreated and irradiated choroidal melanomas. Eur J Ophthalmol. 2001 Apr-Jun; 11(2):150-5.
    View in: PubMed
  75. Ray S, Gragoudas E. Neuroretinitis. Int Ophthalmol Clin. 2001; 41(1):83-102.
    View in: PubMed
  76. Renno RZ, Delori FC, Holzer RA, Gragoudas ES, Miller JW. Photodynamic therapy using Lu-Tex induces apoptosis in vitro, and its effect is potentiated by angiostatin in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci. 2000 Nov; 41(12):3963-71.
    View in: PubMed
  77. Li W, Gragoudas ES, Egan KM. Metastatic melanoma death rates by anatomic site after proton beam irradiation for uveal melanoma. Arch Ophthalmol. 2000 Aug; 118(8):1066-70.
    View in: PubMed
  78. Gragoudas ES, Egan KM. Uveal melanoma: a rare malignancy. Ophthalmology. 2000 Aug; 107(8):1441-2.
    View in: PubMed
  79. Li W, Judge H, Gragoudas ES, Seddon JM, Egan KM. Patterns of tumor initiation in choroidal melanoma. Cancer Res. 2000 Jul 15; 60(14):3757-60.
    View in: PubMed
  80. Gragoudas ES. Discussion by evangelos S. Gragoudas, MD Ophthalmology. 2000 Jul; 107(7):1387-8.
    View in: PubMed
  81. Gragoudas ES, Lane AM, Regan S, Li W, Judge HE, Munzenrider JE, Seddon JM, Egan KM. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol. 2000 Jun; 118(6):773-8.
    View in: PubMed
  82. Ambati J, Gragoudas ES, Miller JW, You TT, Miyamoto K, Delori FC, Adamis AP. Transscleral delivery of bioactive protein to the choroid and retina. Invest Ophthalmol Vis Sci. 2000 Apr; 41(5):1186-91.
    View in: PubMed
  83. Ambati J, Canakis CS, Miller JW, Gragoudas ES, Edwards A, Weissgold DJ, Kim I, Delori FC, Adamis AP. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci. 2000 Apr; 41(5):1181-5.
    View in: PubMed
  84. Sickenberg M, Schmidt-Erfurth U, Miller JW, Pournaras CJ, Zografos L, Piguet B, Donati G, Laqua H, Barbazetto I, Gragoudas ES, Lane AM, Birngruber R, van den Bergh H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol. 2000 Mar; 118(3):327-36.
    View in: PubMed
  85. Levin LA, Gragoudas ES, Lessell S. Endothelial cell loss in irradiated optic nerves. Ophthalmology. 2000 Feb; 107(2):370-4.
    View in: PubMed
  86. Tolentino MJ, Husain D, Theodosiadis P, Gragoudas ES, Connolly E, Kahn J, Cleland J, Adamis AP, Cuthbertson A, Miller JW. Angiography of fluoresceinated anti-vascular endothelial growth factor antibody and dextrans in experimental choroidal neovascularization. Arch Ophthalmol. 2000 Jan; 118(1):78-84.
    View in: PubMed
  87. Reinke MH, Canakis C, Husain D, Michaud N, Flotte TJ, Gragoudas ES, Miller JW. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology. 1999 Oct; 106(10):1915-23.
    View in: PubMed
  88. Cutler C, Gragoudas ES. Choroidal metastases. Case 2: lung cancer. J Clin Oncol. 1999 Oct; 17(10):3358-9.
    View in: PubMed
  89. Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, Zografos L, Piguet B, Donati G, Lane AM, Birngruber R, van den Berg H, Strong A, Manjuris U, Gray T, Fsadni M, Bressler NM, Gragoudas ES. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol. 1999 Sep; 117(9):1161-73.
    View in: PubMed
  90. Husain D, Kramer M, Kenny AG, Michaud N, Flotte TJ, Gragoudas ES, Miller JW. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Invest Ophthalmol Vis Sci. 1999 Sep; 40(10):2322-31.
    View in: PubMed
  91. Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol. 1999 Sep; 117(9):1177-87.
    View in: PubMed
  92. Gragoudas ES, Li W, Lane AM, Munzenrider J, Egan KM. Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology. 1999 Aug; 106(8):1571-7; discussion 1577-8.
    View in: PubMed
  93. Sinilnikova OM, Egan KM, Quinn JL, Boutrand L, Lenoir GM, Stoppa-Lyonnet D, Desjardins L, Levy C, Goldgar D, Gragoudas ES. Germline brca2 sequence variants in patients with ocular melanoma. Int J Cancer. 1999 Jul 30; 82(3):325-8.
    View in: PubMed
  94. Egan KM, Quinn JL, Gragoudas ES. Childbearing history associated with improved survival in choroidal melanoma. Arch Ophthalmol. 1999 Jul; 117(7):939-42.
    View in: PubMed
  95. Regan S, Judge HE, Gragoudas ES, Egan KM. Iris color as a prognostic factor in ocular melanoma. Arch Ophthalmol. 1999 Jun; 117(6):811-4.
    View in: PubMed
  96. Donovan JT, Prefontaine M, Gragoudas ES. Blindness as a consequence of a paraneoplastic syndrome in a woman with clear cell carcinoma of the ovary. Gynecol Oncol. 1999 Jun; 73(3):424-9.
    View in: PubMed
  97. Chew EY, Sperduto RD, Hiller R, Nowroozi L, Seigel D, Yanuzzi LA, Burton TC, Seddon JM, Gragoudas ES, Haller JA, Blair NP, Farber M. Clinical course of macular holes: the Eye Disease Case-Control Study. Arch Ophthalmol. 1999 Feb; 117(2):242-6.
    View in: PubMed
  98. Adams JA, Paiva KL, Munzenrider JE, Miller JW, Gragoudas ES. Proton beam therapy for age-related macular degeneration: development of a standard plan. Med Dosim. 1999; 24(4):233-8.
    View in: PubMed
  99. Weissgold DJ, Gragoudas ES, Kent C, Amrein PC, Dickersin GR. Choroidal metastasis from olfactory neuroblastoma (esthesioneuroblastoma). Retina. 1999; 19(5):459-62.
    View in: PubMed
  100. Schmidt-Erfurth U, Miller J, Sickenberg M, Bunse A, Laqua H, Gragoudas E, Zografos L, Birngruber R, van den Bergh H, Strong A, Manjuris U, Fsadni M, Lane AM, Piguet B, Bressler NM. Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol. 1998 May; 236(5):365-74.
    View in: PubMed
  101. Sperduto RD, Hiller R, Chew E, Seigel D, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Seddon JM, Yannuzzi LA. Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology. 1998 May; 105(5):765-71.
    View in: PubMed
  102. Weissgold DJ, Gragoudas ES, Green JP, Kent CJ, Rubin PA. Eye-sparing treatment of massive extrascleral extension of choroidal melanoma. Arch Ophthalmol. 1998 Apr; 116(4):531-3.
    View in: PubMed
  103. Egan KM, Ryan LM, Gragoudas ES. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-dependent covariates. Arch Ophthalmol. 1998 Mar; 116(3):366-70.
    View in: PubMed
  104. Pineda R, Theodossiadis PG, Gonzalez VH, Hu LK, Hart LJ, Gragoudas ES, Young LH. Establishment of a rabbit model of extrascleral extension of ocular melanoma. Retina. 1998; 18(4):368-72.
    View in: PubMed
  105. Gragoudas ES. A randomized, controlled trial of varying radiation doses in the treatment of choroidal melanoma. Trans Am Ophthalmol Soc. 1998; 96:691-720.
    View in: PubMed
  106. Pournaras CJ, Miller JW, Gragoudas ES, Husain D, Munoz JL, Tolentino MJ, Kuroki M, Adamis AP. Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina. Arch Ophthalmol. 1997 Dec; 115(12):1553-8.
    View in: PubMed
  107. Haimovici R, Gragoudas ES, Duker JS, Sjaarda RN, Eliott D. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology. 1997 Oct; 104(10):1653-60.
    View in: PubMed
  108. Haynie GD, Shen TT, Gragoudas ES, Young LH. Flow cytometry analysis of peripheral blood lymphocytes in patients with choroidal melanoma. Am J Ophthalmol. 1997 Sep; 124(3):357-61.
    View in: PubMed
  109. Husain D, Miller JW, Kenney AG, Michaud N, Flotte TJ, Gragoudas ES. Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative. Ophthalmology. 1997 Aug; 104(8):1242-50.
    View in: PubMed
  110. Haimovici R, Gragoudas ES, Gregor Z, Pesavento RD, Mieler WF, Duker JS. Choroidal metastases from renal cell carcinoma. Ophthalmology. 1997 Jul; 104(7):1152-8.
    View in: PubMed
  111. Kim RY, Hu LK, Flotte TJ, Gragoudas ES, Young LH. Digital angiography of experimental choroidal melanomas using benzoporphyrin derivative. Am J Ophthalmol. 1997 Jun; 123(6):810-6.
    View in: PubMed
  112. Lane AM, Egan KM, Yang J, Saornil MA, Alroy J, Albert D, Gragoudas ES. An evaluation of tumour vascularity as a prognostic indicator in uveal melanoma. Melanoma Res. 1997 Jun; 7(3):237-42.
    View in: PubMed
  113. Gragoudas ES. 1996 Jules Gonin Lecture of the Retina Research Foundation. Long-term results after proton irradiation of uveal melanomas. Graefes Arch Clin Exp Ophthalmol. 1997 May; 235(5):265-7.
    View in: PubMed
  114. Ciulla TA, Bains RA, Jakobiec FA, Topping TM, Gragoudas ES. Uveal lymphoid neoplasia: a clinical-pathologic correlation and review of the early form. Surv Ophthalmol. 1997 May-Jun; 41(6):467-76.
    View in: PubMed
  115. Haimovici R, Kramer M, Miller JW, Hasan T, Flotte TJ, Schomacker KT, Gragoudas ES. Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye. Curr Eye Res. 1997 Feb; 16(2):83-90.
    View in: PubMed
  116. Palmer JD, Gragoudas ES. Advances in treatment of retinal angiomas. Int Ophthalmol Clin. 1997; 37(4):159-70.
    View in: PubMed
  117. Reinke MH, Gragoudas ES. Unusual hemorrhagic lesions masquerading as choroidal melanoma. Int Ophthalmol Clin. 1997; 37(4):135-47.
    View in: PubMed
  118. Smith JA, Gragoudas ES, Dreyer EB. Uveal metastases. Int Ophthalmol Clin. 1997; 37(4):183-99.
    View in: PubMed
  119. Foster BS, Gragoudas ES, Young LH. Photodynamic therapy of choroidal melanoma. Int Ophthalmol Clin. 1997; 37(4):117-26.
    View in: PubMed
  120. Kim RY, Hu LK, Foster BS, Gragoudas ES, Young LH. Photodynamic therapy of pigmented choroidal melanomas of greater than 3-mm thickness. Ophthalmology. 1996 Dec; 103(12):2029-36.
    View in: PubMed
  121. Wang X, Egan KM, Gragoudas ES, Kelsey KT. Constitutional alterations in p16 in patients with uveal melanoma. Melanoma Res. 1996 Dec; 6(6):405-10.
    View in: PubMed
  122. Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K, Ferrara N, Adamis AP. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology. 1996 Nov; 103(11):1820-8.
    View in: PubMed
  123. Tolentino MJ, Miller JW, Gragoudas ES, Chatzistefanou K, Ferrara N, Adamis AP. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol. 1996 Aug; 114(8):964-70.
    View in: PubMed
  124. Husain D, Miller JW, Michaud N, Connolly E, Flotte TJ, Gragoudas ES. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. Arch Ophthalmol. 1996 Aug; 114(8):978-85.
    View in: PubMed
  125. Kramer M, Miller JW, Michaud N, Moulton RS, Hasan T, Flotte TJ, Gragoudas ES. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. Ophthalmology. 1996 Mar; 103(3):427-38.
    View in: PubMed
  126. Young LH, Howard MA, Hu LK, Kim RY, Gragoudas ES. Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative. Arch Ophthalmol. 1996 Feb; 114(2):186-92.
    View in: PubMed
  127. Schmidt-Erfurth U, Flotte TJ, Gragoudas ES, Schomacker K, Birngruber R, Hasan T. Benzoporphyrin-lipoprotein-mediated photodestruction of intraocular tumors. Exp Eye Res. 1996 Jan; 62(1):1-10.
    View in: PubMed
  128. Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES, Ferrara N, Folkman J, D'Amore PA, Miller JW. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol. 1996 Jan; 114(1):66-71.
    View in: PubMed
  129. Park SS, Walsh SM, Gragoudas ES. Visual-field deficits associated with proton beam irradiation for parapapillary choroidal melanoma. Ophthalmology. 1996 Jan; 103(1):110-6.
    View in: PubMed
  130. Kaiser PK, Gragoudas ES. The subretinal fibrosis and uveitis syndrome. Int Ophthalmol Clin. 1996; 36(1):145-52.
    View in: PubMed
  131. Haimovici R, Mukai S, Schachat AP, Haynie GD, Thomas MA, Meredith TA, Gragoudas ES. Rhegmatogenous retinal detachment in eyes with uveal melanoma. Retina. 1996; 16(6):488-96.
    View in: PubMed
  132. Ciulla TA, Gragoudas ES. Serpiginous choroiditis. Int Ophthalmol Clin. 1996; 36(1):135-43.
    View in: PubMed
  133. Hiller R, Seigel D, Sperduto RD, Blair N, Burton TC, Farber MD, Gragoudas ES, Gunter EW, Haller J, Seddon JM, et al. Serum zinc and serum lipid profiles in 778 adults. Ann Epidemiol. 1995 Nov; 5(6):490-6.
    View in: PubMed
  134. Hu LK, Hasan T, Gragoudas ES, Young LH. Photoimmunotherapy of human uveal melanoma cells. Exp Eye Res. 1995 Oct; 61(4):385-91.
    View in: PubMed
  135. Miller JW, Walsh AW, Kramer M, Hasan T, Michaud N, Flotte TJ, Haimovici R, Gragoudas ES. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol. 1995 Jun; 113(6):810-8.
    View in: PubMed
  136. Gonzalez VH, Hu LK, Theodossiadis PG, Flotte TJ, Gragoudas ES, Young LH. Photodynamic therapy of pigmented choroidal melanomas. Invest Ophthalmol Vis Sci. 1995 Apr; 36(5):871-8.
    View in: PubMed
  137. Friedman E, Krupsky S, Lane AM, Oak SS, Friedman ES, Egan K, Gragoudas ES. Ocular blood flow velocity in age-related macular degeneration. Ophthalmology. 1995 Apr; 102(4):640-6.
    View in: PubMed
  138. Gragoudas ES, Egan KM, Walsh SM, Regan S, Munzenrider JE, Taratuta V. Lens changes after proton beam irradiation for uveal melanoma. Am J Ophthalmol. 1995 Feb; 119(2):157-64.
    View in: PubMed
  139. Schmidt-Erfurth U, Hasan T, Gragoudas E, Birngruber R. [Selective occlusion of subretinal neovascularization with photodynamic therapy]. Ophthalmologe. 1994 Dec; 91(6):789-95.
    View in: PubMed
  140. Park SS, Theodossiadis PG, Gragoudas ES. Intrascleral foreign body simulating extrascleral extension of uveal melanoma. Arch Ophthalmol. 1994 Dec; 112(12):1620-1.
    View in: PubMed
  141. Schmidt-Erfurth U, Hasan T, Gragoudas E, Michaud N, Flotte TJ, Birngruber R. Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology. 1994 Dec; 101(12):1953-61.
    View in: PubMed
  142. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 1994 Nov 9; 272(18):1413-20.
    View in: PubMed
  143. Theodosiadis PG, Moulton RS, Walsh AW, Gragoudas ES, D'Amico DJ. Experimental transient exudative retinal detachment in the rat. Arch Ophthalmol. 1994 Sep; 112(9):1236-42.
    View in: PubMed
  144. Schmidt-Erfurth U, Hasan T, Flotte T, Gragoudas E, Birngruber R. [Photodynamic therapy of experimental, intraocular tumors with benzoporphyrin-lipoprotein]. Ophthalmologe. 1994 Jun; 91(3):348-56.
    View in: PubMed
  145. Young LH, Egan KM, Walsh SM, Gragoudas ES. Familial uveal melanoma. Am J Ophthalmol. 1994 Apr 15; 117(4):516-20.
    View in: PubMed
  146. Hope-Ross M, Yannuzzi LA, Gragoudas ES, Guyer DR, Slakter JS, Sorenson JA, Krupsky S, Orlock DA, Puliafito CA. Adverse reactions due to indocyanine green. Ophthalmology. 1994 Mar; 101(3):529-33.
    View in: PubMed
  147. Schmidt-Erfurth U, Bauman W, Gragoudas E, Flotte TJ, Michaud NA, Birngruber R, Hasan T. Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. Ophthalmology. 1994 Jan; 101(1):89-99.
    View in: PubMed
  148. Hu LK, Huh K, Gragoudas ES, Young LH. Establishment of pigmented choroidal melanomas in a rabbit model. Retina. 1994; 14(3):264-9.
    View in: PubMed
  149. Young LH, Gragoudas ES. Macular uveal melanoma treated with proton beam irradiation. 10-year follow-up observation with histopathologic correlation. Retina. 1994; 14(1):43-6.
    View in: PubMed
  150. Samy CN, Gragoudas ES. Laser photocoagulation treatment of central serous chorioretinopathy. Int Ophthalmol Clin. 1994; 34(3):109-19.
    View in: PubMed
  151. Guyer DR, Yannuzzi LA, Krupsky S, Slakter JS, Sorenson JA, Orlock D, Friedman E, Gragoudas ES. Digital indocyanine-green videoangiography of intraocular tumors. Semin Ophthalmol. 1993 Dec; 8(4):224-9.
    View in: PubMed
  152. Gragoudas ES, Egan KM, Saornil MA, Walsh SM, Albert DM, Seddon JM. The time course of irradiation changes in proton beam-treated uveal melanomas. Ophthalmology. 1993 Oct; 100(10):1555-9; discussion 1560.
    View in: PubMed
  153. Egan KM, Walsh SM, Seddon JM, Gragoudas ES. An evaluation of the influence of reproductive factors on the risk of metastases from uveal melanoma. Ophthalmology. 1993 Aug; 100(8):1160-5; discussion 1166.
    View in: PubMed
  154. Kolodny NH, Kohler SJ, Rettig ES, Botti PA, D'Amico DJ, Gragoudas ES. A feasibility study of 23Na magnetic resonance imaging of human and rabbit vitreal disorders. Invest Ophthalmol Vis Sci. 1993 May; 34(6):1917-22.
    View in: PubMed
  155. Ajani UA, Seddon JM, Hsieh CC, Egan KM, Albert DM, Gragoudas ES. Occupation and risk of uveal melanoma. An exploratory study. Cancer. 1992 Dec 15; 70(12):2891-900.
    View in: PubMed
  156. Guyer DR, Adamis AP, Gragoudas ES, Folkman J, Slakter JS, Yannuzzi LA. Systemic antiangiogenic therapy for choroidal neovascularization. What is the role of interferon alfa? Arch Ophthalmol. 1992 Oct; 110(10):1383-4.
    View in: PubMed
  157. Saornil MA, Egan KM, Gragoudas ES, Seddon JM, Walsh SM, Albert DM. Histopathology of proton beam-irradiated vs enucleated uveal melanomas. Arch Ophthalmol. 1992 Aug; 110(8):1112-8.
    View in: PubMed
  158. Guyer DR, Mukai S, Egan KM, Seddon JM, Walsh SM, Gragoudas ES. Radiation maculopathy after proton beam irradiation for choroidal melanoma. Ophthalmology. 1992 Aug; 99(8):1278-85.
    View in: PubMed
  159. Gragoudas ES, Egan KM, Seddon JM, Walsh SM, Munzenrider JE. Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology. 1992 May; 99(5):760-6.
    View in: PubMed
  160. Seddon JM, Egan KM, Zhang Y, Gelles EJ, Glynn RJ, Tucker CA, Gragoudas ES. Evaluation of skin microtopography as a measure of ultraviolet exposure. Invest Ophthalmol Vis Sci. 1992 May; 33(6):1903-8.
    View in: PubMed
  161. Egan KM, Gragoudas ES, Seddon JM, Walsh SM. Smoking and the risk of early metastases from uveal melanoma. Ophthalmology. 1992 Apr; 99(4):537-41.
    View in: PubMed
  162. Gragoudas ES, Egan KM, Arrigg PG, Seddon JM, Glynn RJ, Munzenrider JE. Cataract extraction after proton beam irradiation for malignant melanoma of the eye. Arch Ophthalmol. 1992 Apr; 110(4):475-9.
    View in: PubMed
  163. Gragoudas ES. Current approaches in the management of uveal melanomas. Int Ophthalmol Clin. 1992; 32(2):129-38.
    View in: PubMed
  164. Kohler SJ, Kolodny NH, Celi AC, Burr TA, Weinberg D, D'Amico DJ, Gragoudas ES. In vivo sodium chemical shift imaging. Magn Reson Med. 1992 Jan; 23(1):77-88.
    View in: PubMed
  165. Weinberg DV, Kolodny NH, Kohler SJ, Burr TA, Celi A, D'Amico DJ, Gragoudas ES. Dynamic sodium chemical shift imaging for the study of aqueous humor flow. Invest Ophthalmol Vis Sci. 1991 Jul; 32(8):2212-8.
    View in: PubMed
  166. Destro M, D'Amico DJ, Gragoudas ES, Brockhurst RJ, Pinnolis MK, Albert DM, Topping TM, Puliafito CA. Retinal manifestations of neurofibromatosis. Diagnosis and management. Arch Ophthalmol. 1991 May; 109(5):662-6.
    View in: PubMed
  167. Svitra PP, Budenz D, Albert DM, Koehler AM, Gragoudas E. Proton beam irradiation for treatment of experimental human retinoblastoma. Eur J Ophthalmol. 1991 Apr-Jun; 1(2):57-62.
    View in: PubMed
  168. Seddon J, Gragoudas E, Egan K, Polivogianis L, Finn S, Albert D. Standardized data collection and coding in eye disease epidemiology: the Uveal Melanoma Data System. Ophthalmic Surg. 1991 Mar; 22(3):127-36.
    View in: PubMed
  169. Gragoudas ES, Egan KM, Seddon JM, Glynn RJ, Walsh SM, Finn SM, Munzenrider JE, Spar MD. Survival of patients with metastases from uveal melanoma. Ophthalmology. 1991 Mar; 98(3):383-9; discussion 390.
    View in: PubMed
  170. Austin KL, Palmer JR, Seddon JM, Glynn RJ, Rosenberg L, Gragoudas ES, Kaufman DW, Shapiro S. Case-control study of idiopathic retinal detachment. Int J Epidemiol. 1990 Dec; 19(4):1045-50.
    View in: PubMed
  171. Seddon JM, Gragoudas ES, Glynn RJ, Egan KM, Albert DM, Blitzer PH. Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol. 1990 Sep; 108(9):1274-80.
    View in: PubMed
  172. Seddon JM, Sahagian CR, Glynn RJ, Sperduto RD, Gragoudas ES. Evaluation of an iris color classification system. The Eye Disorders Case-Control Study Group. Invest Ophthalmol Vis Sci. 1990 Aug; 31(8):1592-8.
    View in: PubMed
  173. Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Howard S, Fante RG, Albert DM. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology. 1990 Jun; 97(6):769-77.
    View in: PubMed
  174. Smith EV, Kolodny NH, Gragoudas ES, Egan KM, Finn S, D'Amico DJ, Seddon JM. An NMR blood test for uveal melanoma? Invest Ophthalmol Vis Sci. 1990 May; 31(5):993-7.
    View in: PubMed
  175. Smith EV, Gragoudas ES, Kolodny NH, D'Amico DJ. Magnetic resonance imaging: an emerging technique for the diagnosis of ocular disorders. Int Ophthalmol. 1990 Mar; 14(2):119-24.
    View in: PubMed
  176. Suit HD, Goitein M, Munzenrider J, Verhey L, Urie M, Gragoudas E, Koehler A, Gottschalk B, Sisterson J, Tatsuzaki H, et al. Increased efficacy of radiation therapy by use of proton beam. Strahlenther Onkol. 1990 Jan; 166(1):40-4.
    View in: PubMed
  177. Lischko AM, Seddon JM, Gragoudas ES, Egan KM, Glynn RJ. Evaluation of prior primary malignancy as a determinant of uveal melanoma. A case-control study. Ophthalmology. 1989 Dec; 96(12):1716-21.
    View in: PubMed
  178. Glynn RJ, Seddon JM, Gragoudas ES, Egan KM, Hart LJ. Evaluation of tumor regression and other prognostic factors for early and late metastasis after proton irradiation of uveal melanoma. Ophthalmology. 1989 Oct; 96(10):1566-73.
    View in: PubMed
  179. Munzenrider JE, Verhey LJ, Gragoudas ES, Seddon JM, Urie M, Gentry R, Birnbaum S, Ruotolo DM, Crowell C, McManus P, et al. Conservative treatment of uveal melanoma: local recurrence after proton beam therapy. Int J Radiat Oncol Biol Phys. 1989 Sep; 17(3):493-8.
    View in: PubMed
  180. Egan KM, Gragoudas ES, Seddon JM, Glynn RJ, Munzenreider JE, Goitein M, Verhey L, Urie M, Koehler A. The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmology. 1989 Sep; 96(9):1377-82; discussion 1382-3.
    View in: PubMed
  181. Flotte TJ, Seddon JM, Zhang YQ, Glynn RJ, Egan KM, Gragoudas ES. A computerized image analysis method for measuring elastic tissue. J Invest Dermatol. 1989 Sep; 93(3):358-62.
    View in: PubMed
  182. Gragoudas ES. Current treatment of metastatic choroidal tumors. Oncology (Williston Park). 1989 Jun; 3(6):103-10; discussion 111.
    View in: PubMed
  183. Panagopoulos JA, Svitra PP, Puliafito CA, Gragoudas ES. Photodynamic therapy for experimental intraocular melanoma using chloroaluminum sulfonated phthalocyanine. Arch Ophthalmol. 1989 Jun; 107(6):886-90.
    View in: PubMed
  184. Char DH, Gragoudas ES, Phillips TL. Uveal melanoma management. Br J Ophthalmol. 1989 Jun; 73(6):476-7.
    View in: PubMed
  185. Kolodny NH, Gragoudas ES, D'Amico DJ, Albert DM. Magnetic resonance imaging and spectroscopy of intraocular tumors. Surv Ophthalmol. 1989 May-Jun; 33(6):502-14.
    View in: PubMed
  186. Friedman E, Ivry M, Ebert E, Glynn R, Gragoudas E, Seddon J. Increased scleral rigidity and age-related macular degeneration. Ophthalmology. 1989 Jan; 96(1):104-8.
    View in: PubMed
  187. Polivogianis L, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Comparison of transillumination and histologic slide measurements of tumor diameter in uveal melanoma. Ophthalmology. 1988 Nov; 95(11):1576-82.
    View in: PubMed
  188. Munzenrider JE, Gragoudas ES, Seddon JM, Sisterson J, McNulty P, Birnbaum S, Johnson K, Austin-Seymour M, Slater J, Goitein MM, et al. Conservative treatment of uveal melanoma: probability of eye retention after proton treatment. Int J Radiat Oncol Biol Phys. 1988 Sep; 15(3):553-8.
    View in: PubMed
  189. Ward RC, Gragoudas ES, Pon DM, Albert DM. Abnormal scleral findings in uveal effusion syndrome. Am J Ophthalmol. 1988 Aug 15; 106(2):139-46.
    View in: PubMed
  190. Gragoudas ES, Seddon JM, Egan KM, Glynn RJ, Goitein M, Munzenrider J, Verhey L, Urie M, Koehler A. Metastasis from uveal melanoma after proton beam irradiation. Ophthalmology. 1988 Jul; 95(7):992-9.
    View in: PubMed
  191. Smith EV, Kolodny NH, Gragoudas ES, Rubin LG, Seddon JH, D'Amico DJ. Safety and effectiveness of magnetic resonance imaging of choroidal melanoma patients with episcleral tantalum rings after proton beam irradiation. Am J Ophthalmol. 1988 Jun 15; 105(6):695-6.
    View in: PubMed
  192. Kolodny NH, Gragoudas ES, D'Amico DJ, Seddon JM, Minichiello M, Murphy EJ, Albert DM. Preliminary results on phosphorus-31 nuclear magnetic resonance evaluation of human uveal melanoma in enucleated eyes. Ophthalmology. 1988 May; 95(5):666-73.
    View in: PubMed
  193. Bressler NM, Bressler SB, Seddon JM, Gragoudas ES, Jacobson LP. Drusen characteristics in patients with exudative versus non-exudative age-related macular degeneration. Retina. 1988; 8(2):109-14.
    View in: PubMed
  194. Bressler SB, Bressler NM, Seddon JM, Gragoudas ES, Jacobson LP. Interobserver and intraobserver reliability in the clinical classification of drusen. Retina. 1988; 8(2):102-8.
    View in: PubMed
  195. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol. 1988 Jan-Feb; 32(4):239-51.
    View in: PubMed
  196. Kolodny NH, Gragoudas ES, D'Amico DJ, Kohler SJ, Seddon JM, Murphy EJ, Yun C, Albert DM. Proton and sodium 23 magnetic resonance imaging of human ocular tissues. A model study. Arch Ophthalmol. 1987 Nov; 105(11):1532-6.
    View in: PubMed
  197. Bressler NM, Gragoudas ES. Retinitis pigmentosa and retinal neovascularization. Ophthalmology. 1987 Jul; 94(7):895.
    View in: PubMed
  198. Seddon JM, Polivogianis L, Hsieh CC, Albert DM, Gamel JW, Gragoudas ES. Death from uveal melanoma. Number of epithelioid cells and inverse SD of nucleolar area as prognostic factors. Arch Ophthalmol. 1987 Jun; 105(6):801-6.
    View in: PubMed
  199. Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Munzenrider JE, Austin-Seymour M, Goitein M, Verhey L, Urie M, Koehler A. Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation. Ophthalmology. 1987 Apr; 94(4):354-61.
    View in: PubMed
  200. Gragoudas ES, Seddon JM, Egan K, Glynn R, Munzenrider J, Austin-Seymour M, Goitein M, Verhey L, Urie M, Koehler A. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology. 1987 Apr; 94(4):349-53.
    View in: PubMed
  201. Bressler NM, Bressler SB, Gragoudas ES. Clinical characteristics of choroidal neovascular membranes. Arch Ophthalmol. 1987 Feb; 105(2):209-13.
    View in: PubMed
  202. Margo CE, Pavan PR, Gendelman D, Gragoudas E. Bilateral melanocytic uveal tumors associated with systemic non-ocular malignancy. Malignant melanomas or benign paraneoplastic syndrome? Retina. 1987; 7(3):137-41.
    View in: PubMed
  203. Morgan CM, Gragoudas ES. Limited choroidal hemorrhage mistaken for a choroidal melanoma. Ophthalmology. 1987 Jan; 94(1):41-6.
    View in: PubMed
  204. Morgan CM, Gragoudas ES. Branch retinal artery occlusion associated with recurrent toxoplasmic retinochoroiditis. Arch Ophthalmol. 1987 Jan; 105(1):130-1.
    View in: PubMed
  205. Gragoudas ES, Seddon JM, Egan KM, Polivogianis L, Hsieh CC, Goitein M, Verhey L, Munzenrider J, Austin-Seymour M, Urie M, et al. Prognostic factors for metastasis following proton beam irradiation of uveal melanomas. Ophthalmology. 1986 May; 93(5):675-80.
    View in: PubMed
  206. Seddon JM, Gragoudas ES, Polivogianis L, Hsieh CC, Egan KM, Goitein M, Verhey L, Munzenrider J, Austin-Seymour M, Urie M, et al. Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmology. 1986 May; 93(5):666-74.
    View in: PubMed
  207. Gragoudas ES. Proton beam therapy of uveal melanomas. Arch Ophthalmol. 1986 Mar; 104(3):349-51.
    View in: PubMed
  208. Seddon JM, Polivogianis L, Gragoudas ES, Hsieh CC, Egan KM. Enucleation vs cobalt 60 irradiation of melanomas. Arch Ophthalmol. 1986 Feb; 104(2):175-6.
    View in: PubMed
  209. Seddon JM, Gragoudas E, Albert D, Hsieh CC, Polivogianis L, Egan K. Echographic and histologic tumor height measurements in uveal melanoma. Am J Ophthalmol. 1986 Jan 15; 101(1):126-8.
    View in: PubMed
  210. Gragoudas ES, Seddon JM. Management of choroidal melanomas. Int Ophthalmol Clin. 1986; 26(2):145-58.
    View in: PubMed
  211. Morgan CM, Foster CS, D'Amico DJ, Gragoudas ES. Retinal vasculitis in polyarteritis nodosa. Retina. 1986; 6(4):205-9.
    View in: PubMed
  212. Riedel KG, Svitra PP, Albert DM, Seddon JM, Gragoudas ES, Koehler AM, Coleman DJ. [Combined hyperthermia and proton irradiation: a new method in the treatment of malignant melanoma of the choroid?]. Fortschr Ophthalmol. 1986; 83(4):483-8.
    View in: PubMed
  213. Munzenrider JE, Austin-Seymour M, Blitzer PJ, Gentry R, Goitein M, Gragoudas ES, Johnson K, Koehler AM, McNulty P, Moulton G, et al. Proton therapy at Harvard. Strahlentherapie. 1985 Dec; 161(12):756-63.
    View in: PubMed
  214. Riedel KG, Svitra PP, Seddon JM, Albert DM, Gragoudas ES, Koehler AM, Coleman DJ, Torpey J, Lizzi FL, Driller J. Proton beam irradiation and hyperthermia. Effects on experimental choroidal melanoma. Arch Ophthalmol. 1985 Dec; 103(12):1862-9.
    View in: PubMed
  215. Ferry AP, Blair CJ, Gragoudas ES, Volk SC. Pathologic examination of ciliary body melanoma treated with proton beam irradiation. Arch Ophthalmol. 1985 Dec; 103(12):1849-53.
    View in: PubMed
  216. Fournier GA, Saulenas AM, Seddon JM, Goitein M, Albert DM, Polivogianis L, Gragoudas E. The effects of pre-enucleation irradiation on the development of metastases from intraocular Greene melanoma in hamsters. Am J Ophthalmol. 1985 Nov 15; 100(5):669-77.
    View in: PubMed
  217. Weinhaus RS, Seddon JM, Albert DM, Gragoudas ES, Robinson N. Prognostic factor study of survival after enucleation for juxtapapillary melanomas. Arch Ophthalmol. 1985 Nov; 103(11):1673-7.
    View in: PubMed
  218. Bressler NM, Gragoudas ES. Neovascularization of the optic disk associated with atypical retinitis pigmentosa. Am J Ophthalmol. 1985 Sep 15; 100(3):431-3.
    View in: PubMed
  219. Chess J, Henkind P, Albert DM, Gragoudas ES, Reidel K, Weiss J, McMahon M, Abramson D. Uveal melanoma presenting after cataract extraction with intraocular lens implantation. Ophthalmology. 1985 Jun; 92(6):827-30.
    View in: PubMed
  220. Seddon JM, Gragoudas ES, Albert DM, Hsieh CC, Polivogianis L, Friedenberg GR. Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am J Ophthalmol. 1985 Mar 15; 99(3):282-90.
    View in: PubMed
  221. Gragoudas ES, Seddon J, Goitein M, Verhey L, Munzenrider J, Urie M, Suit HD, Blitzer P, Koehler A. Current results of proton beam irradiation of uveal melanomas. Ophthalmology. 1985 Feb; 92(2):284-91.
    View in: PubMed
  222. Goitein M, Suit HD, Gragoudas E, Koehler AM, Wilson R. Potential for low-LET charged-particle radiation therapy in cancer. Radiat Res Suppl. 1985; 8:S297-309.
    View in: PubMed
  223. Austin-Seymour M, Munzenrider JE, Goitein M, Gentry R, Gragoudas E, Koehler AM, McNulty P, Osborne E, Ryugo DK, Seddon J, et al. Progress in low-LET heavy particle therapy: intracranial and paracranial tumors and uveal melanomas. Radiat Res Suppl. 1985; 8:S219-26.
    View in: PubMed
  224. Gragoudas ES, Goitein M, Seddon J, Verhey L, Munzenrider J, Urie M, Suit HD, Blitzer P, Johnson KN, Koehler A. Preliminary results of proton beam irradiation of macular and paramacular melanomas. Br J Ophthalmol. 1984 Jul; 68(7):479-85.
    View in: PubMed
  225. Puliafito CA, Wasson PJ, Steinert RF, Gragoudas ES. Neodymium-YAG laser surgery on experimental vitreous membranes. Arch Ophthalmol. 1984 Jun; 102(6):843-7.
    View in: PubMed
  226. Urano M, Verhey LJ, Goitein M, Tepper JE, Suit HD, Mendiondo O, Gragoudas ES, Koehler A. Relative biological effectiveness of modulated proton beams in various murine tissues. Int J Radiat Oncol Biol Phys. 1984 Apr; 10(4):509-14.
    View in: PubMed
  227. Borodic GE, Gragoudas ES, Edward WO, Brockhurst RJ. Peripapillary subretinal neovascularization and serous macular detachment. Association with congenital optic nerve pits. Arch Ophthalmol. 1984 Feb; 102(2):229-31.
    View in: PubMed
  228. Seddon JM, Gragoudas ES, Albert DM. Ciliary body and choroidal melanomas treated by proton beam irradiation. Histopathologic study of eyes. Arch Ophthalmol. 1983 Sep; 101(9):1402-8.
    View in: PubMed
  229. Suit H, Goitein M, Munzenrider J, Verhey L, Blitzer P, Gragoudas E, Koehler AM, Urie M, Gentry R, Shipley W, Urano M, Duttenhaver J, Wagner M. Evaluation of the clinical applicability of proton beams in definitive fractionated radiation therapy. Int J Radiat Oncol Biol Phys. 1982 Dec; 8(12):2199-205.
    View in: PubMed
  230. Seddon JM, MacLaughlin DT, Albert DM, Gragoudas ES, Ference M. Uveal melanomas presenting during pregnancy and the investigation of oestrogen receptors in melanomas. Br J Ophthalmol. 1982 Nov; 66(11):695-704.
    View in: PubMed
  231. Wilkes SR, Gragoudas ES. Regression patterns of uveal melanomas after proton beam irradiation. Ophthalmology. 1982 Jul; 89(7):840-4.
    View in: PubMed
  232. Gragoudas ES, Goitein M, Verhey L, Munzenreider J, Urie M, Suit H, Koehler A. Proton beam irradiation of uveal melanomas. Results of 5 1/2-year study. Arch Ophthalmol. 1982 Jun; 100(6):928-34.
    View in: PubMed
  233. Lubin JR, Gragoudas ES, Albert DM. Choroidal neovascularization associated with malignant melanoma: a case report. Acta Ophthalmol (Copenh). 1982 Jun; 60(3):412-8.
    View in: PubMed
  234. Zinn KM, Stein/Pokorny K, Jakobiec FA, Friedman AH, Gragoudas ES, Ritch R. Proton-beam irradiated epithelioid cell melanoma of the ciliary body. Ophthalmology. 1981 Dec; 88(12):1315-21.
    View in: PubMed
  235. Gragoudas ES, Regan CD. Peripapillary subretinal neovascularization in presumed sarcoidosis. Arch Ophthalmol. 1981 Jul; 99(7):1194-7.
    View in: PubMed
  236. Hedges TR, Gragoudas ES. Traumatic anterior ischemic optic neuropathy. Ann Ophthalmol. 1981 May; 13(5):625-8.
    View in: PubMed
  237. Gragoudas ES, Goitein M, Verhey L, Munzenreider J, Suit HD, Koehler A. Proton beam irradiation. An alternative to enucleation for intraocular melanomas. Ophthalmology. 1980 Jun; 87(6):571-81.
    View in: PubMed
  238. Suit HD, Goitein M, Munzenrider JE, Verhey L, Gragoudas E, Koehler AM, Urano M, Shipley WU, Linggood RM, Friedberg C, Wagner M. Clinical experience with proton beam radiation therapy. J Can Assoc Radiol. 1980 Mar; 31(1):35-9.
    View in: PubMed
  239. Lubin JR, Gragoudas ES, Albert DM, Weichselbaum RR. Bilateral malignant choroidal melanomas. Int Ophthalmol Clin. 1980; 20(2):103-15.
    View in: PubMed
  240. Gragoudas ES. The Bragg peak of proton beams for treatment of uveal melanoma. Int Ophthalmol Clin. 1980; 20(2):123-33.
    View in: PubMed
  241. Pitta CG, Steinert RF, Gragoudas ES, Regan CD. Small unilateral foveal hemorrhages in young adults. Am J Ophthalmol. 1980 Jan; 89(1):96-102.
    View in: PubMed
  242. Sinclair SH, Gragoudas ES. Prognosis for rubeosis iridis following central retinal vein occlusion. Br J Ophthalmol. 1979 Nov; 63(11):735-43.
    View in: PubMed
  243. Gragoudas ES, Zakov NZ, Albert DM, Constable IJ. Long-term observations of proton-irradiated monkey eyes. Arch Ophthalmol. 1979 Nov; 97(11):2184-91.
    View in: PubMed
  244. Delori FC, Gragoudas ES. Light source for monochromatic ophthalmoscopy and fluorescein angiography. Arch Ophthalmol. 1979 Jul; 97(7):1349-50.
    View in: PubMed
  245. Friberg TR, Gragoudas ES, Regan CD. Talc emboli and macular ischemia in intravenous drug abuse. Arch Ophthalmol. 1979 Jun; 97(6):1089-91.
    View in: PubMed
  246. Hedges TR, Sinclair SH, Gragoudas ES. Evidence for vasculitis in acute posterior multifocal placoid pigment epitheliopathy. Ann Ophthalmol. 1979 Apr; 11(4):539-42.
    View in: PubMed
  247. Gragoudas ES, Carroll JM. Multiple choroidal metastasis from bronchial carcinoid treated with photocoagulation and proton beam irradiation. Am J Ophthalmol. 1979 Mar; 87(3):299-304.
    View in: PubMed
  248. Ducrey NM, Delori FC, Gragoudas ES. Monochromatic ophthalmoscopy and fundus photography. II. The pathological fundus. Arch Ophthalmol. 1979 Feb; 97(2):288-93.
    View in: PubMed
  249. Gragoudas ES, Goitein M, Koehler A, Wagner MS, Verhey L, Tepper J, Suit HD, Schneider RJ, Johnson KN. Proton irradiation of malignant melanoma of the ciliary body. Br J Ophthalmol. 1979 Feb; 63(2):135-9.
    View in: PubMed
  250. Thomas JV, Schwartz PL, Gragoudas ES. Von Hippel's disease in association with von Recklinghausen's neurofibromatosis. Br J Ophthalmol. 1978 Sep; 62(9):604-8.
    View in: PubMed
  251. Schwartz PL, Gragoudas ES, Lapus JV. Peripapillary subretinal neovascularization in chronic uveitis. Arch Ophthalmol. 1978 May; 96(5):836-8.
    View in: PubMed
  252. Thomas JV, Gragoudas ES, Blair NP, Lapus JV. Correlation of epinephrine use and macular edema in aphakic glaucomatous eyes. Arch Ophthalmol. 1978 Apr; 96(4):625-8.
    View in: PubMed
  253. Delori FC, Gragoudas ES, Francisco R, Pruett RC. Monochromatic ophthalmoscopy and fundus photography. The normal fundus. Arch Ophthalmol. 1977 May; 95(5):861-8.
    View in: PubMed
  254. Gragoudas ES, Goitein M, Koehler AM, Verhey L, Tepper J, Suit HD, Brockhurst R, Constable IJ. Proton irradiation of small choroidal malignant melanomas. Am J Ophthalmol. 1977 May; 83(5):665-73.
    View in: PubMed
  255. Madigan JC, Gragoudas ES, Schwartz PL, Lapus JV. Peripheral retinal neovascularization in sarcoidosis and sickle cell anemia. Am J Ophthalmol. 1977 Mar; 83(3):387-91.
    View in: PubMed
  256. Schepens CL, Gragoudas ES, McMeel JW. Argon laser treatment in supine position. Ann Ophthalmol. 1977 Feb; 9(2):123-34.
    View in: PubMed
  257. Suit HD, Goitein M, Tepper JE, Verhey L, Koehler AM, Schneider R, Gragoudas E. Clinical experience and expectation with protons and heavy ions. Int J Radiat Oncol Biol Phys. 1977; 3:115-25.
    View in: PubMed
  258. Gragoudas ES, McMeel JW. Treatment of rhegmatogenous retinal detachment secondary to proliferative diabetic retinopathy. Am J Ophthalmol. 1976 Jun; 81(6):810-9.
    View in: PubMed
  259. Delori FC, Gragoudas ES. Examination of the ocular fundus with monochromatic light. Ann Ophthalmol. 1976 Jun; 8(6):703-9.
    View in: PubMed
  260. Gragoudas ES, Chandra SR, Friedman E, Klein ML, Van Buskirk M. Disciform degeneration of the macula. II. Pathogenesis. Arch Ophthalmol. 1976 May; 94(5):755-7.
    View in: PubMed
  261. Chandra SR, Gragoudas ES, Friedman E, Van Buskirk EM, Klein ML. Natural history of disciform degeneration of the macula. Am J Ophthalmol. 1974 Oct; 78(4):579-82.
    View in: PubMed
  262. Klein ML, Van Buskirk EM, Friedman E, Gragoudas E, Chandra S. Experience with nontreatment of central serous choroidopathy. Arch Ophthalmol. 1974 Apr; 91(4):247-50.
    View in: PubMed
  263. Bouzas AG, Gragoudas ES, Balodimos MC, Brinegar CH, Aiello LM. Intraocular pressure in diabetes. Relationship to retinopathy and blood glucose level. Arch Ophthalmol. 1971 Apr; 85(4):423-7.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Gragoudas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_